Journal Reviews

BAPU consensus statement on the management of the neuropathic bladder

1 May 2017 | | Paediatric Urology | Anticholinergics, Augmentation, Botolinum toxin A, Neuropathic bladder, Surveillance

The summary of this paper states that a “consensus statement is not a guideline nor a method with which to establish what is best practice. It is a way of surveying practice and providing a benchmark for others to compare...